Set up by the European Commission via Marie Curie actions, the European Industrial Doctorate (EID) emerged in 2012. Open to all research fields, the EID aims at enabling a company and university from different countries of the European Union, to collaborate on a joint research project carried out by a doctoral student. The doctoral student will thus develop skills matching public and private sector needs.
This system echoes the current demands of the labour market, which is becoming more international and requires adaptability and mobility. Moreover, by allowing the doctoral student to carry out their research in collaboration and within a private sector company (where they spend at least 50% of their time), this device responds to one of the reproaches often opposed to doctors: their lack of knowledge of the private sector. The EID makes it possible to improve the employability of doctors by preparing future researchers to the problems of the company, while at the same time conferring an international dimension on the doctoral student’s curriculum.
In order to be eligible for funding under the EID, a project must, as a minimum, bring two beneficiaries from two different Member States into partnership: one from the academic sector and the other from the non-academic sector. However, the EID does not limit itself to the simple financing of an individual thesis and allows to combine several theses (up to 15) within an EID network like the BigCHEM network. BigCHEM is composed of 9 partners from 5 countries representing the pharmaceutical and academic sectors and aims to propose new methods and approaches to analyse the increasing volume of biomedical data in chemistry and life sciences.
Funding is in the form of a grant agreement linking the beneficiaries to the European Commission and covers, in the form of a flat rate, expenses related to: the doctoral student’s salary (including mobility and family expenses), training, networking and network management. However, despite this attractive incentive, France currently benefits only marginally from the EID.
Virginie, Manager, R&D tax credit and Innovation Funding, Leyton France